End-of-day quote
Philippines S.E.
23:00:00 05/06/2024 BST
|
5-day change
|
1st Jan Change
|
0.55
PHP
|
-12.70%
|
|
-1.79%
|
+20.88%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
661.8
|
304.3
|
579.8
|
341
|
205.1
|
144.8
|
Enterprise Value (EV)
1 |
677.6
|
405.5
|
890.1
|
632.1
|
474
|
395.3
|
P/E ratio
|
259
x
|
47.1
x
|
2,804
x
|
-2.21
x
|
59.9
x
|
-29.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.31
x
|
0.96
x
|
2.12
x
|
1.16
x
|
0.61
x
|
0.6
x
|
EV / Revenue
|
2.36
x
|
1.27
x
|
3.25
x
|
2.15
x
|
1.42
x
|
1.63
x
|
EV / EBITDA
|
49.2
x
|
14.8
x
|
56.3
x
|
-3.12
x
|
17.2
x
|
61
x
|
EV / FCF
|
155
x
|
19.7
x
|
31.8
x
|
-5.67
x
|
11.7
x
|
16.3
x
|
FCF Yield
|
0.64%
|
5.07%
|
3.15%
|
-17.6%
|
8.55%
|
6.13%
|
Price to Book
|
6.41
x
|
2.91
x
|
5.51
x
|
-5.79
x
|
-3.35
x
|
-2.13
x
|
Nbr of stocks (in thousands)
|
306,122
|
306,122
|
306,122
|
306,122
|
306,122
|
306,122
|
Reference price
2 |
2.090
|
0.9900
|
1.870
|
1.190
|
0.6500
|
0.4550
|
Announcement Date
|
02/05/19
|
30/06/20
|
18/05/21
|
16/05/22
|
02/05/23
|
26/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
286.7
|
318.4
|
273.7
|
293.5
|
334.1
|
243.2
|
EBITDA
1 |
13.76
|
27.42
|
15.8
|
-202.3
|
27.62
|
6.48
|
EBIT
1 |
11.67
|
24.37
|
12.39
|
-207.4
|
20.83
|
-1
|
Operating Margin
|
4.07%
|
7.65%
|
4.53%
|
-70.68%
|
6.23%
|
-0.41%
|
Earnings before Tax (EBT)
1 |
12.24
|
22.23
|
9.257
|
-207.9
|
18.02
|
-2.437
|
Net income
1 |
2.472
|
6.431
|
0.2043
|
-165.1
|
3.323
|
-4.78
|
Net margin
|
0.86%
|
2.02%
|
0.07%
|
-56.25%
|
0.99%
|
-1.97%
|
EPS
2 |
0.008074
|
0.0210
|
0.000667
|
-0.5393
|
0.0109
|
-0.0156
|
Free Cash Flow
1 |
4.368
|
20.55
|
28.01
|
-111.4
|
40.54
|
24.22
|
FCF margin
|
1.52%
|
6.46%
|
10.24%
|
-37.96%
|
12.13%
|
9.96%
|
FCF Conversion (EBITDA)
|
31.73%
|
74.97%
|
177.28%
|
-
|
146.77%
|
373.68%
|
FCF Conversion (Net income)
|
176.71%
|
319.62%
|
13,709.18%
|
-
|
1,219.89%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
02/05/19
|
30/06/20
|
18/05/21
|
16/05/22
|
02/05/23
|
26/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
15.8
|
101
|
310
|
291
|
269
|
250
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.145
x
|
3.694
x
|
19.64
x
|
-1.439
x
|
9.735
x
|
38.65
x
|
Free Cash Flow
1 |
4.37
|
20.6
|
28
|
-111
|
40.5
|
24.2
|
ROE (net income / shareholders' equity)
|
5.73%
|
11.1%
|
3.27%
|
-230%
|
-246%
|
301%
|
ROA (Net income/ Total Assets)
|
1.23%
|
2.36%
|
0.97%
|
-15.6%
|
1.75%
|
-0.09%
|
Assets
1 |
200.8
|
272
|
21.08
|
1,055
|
190.4
|
5,565
|
Book Value Per Share
2 |
0.3300
|
0.3400
|
0.3400
|
-0.2100
|
-0.1900
|
-0.2100
|
Cash Flow per Share
2 |
0.1400
|
0.1100
|
0.1100
|
0.1300
|
0.1700
|
0.1600
|
Capex
1 |
4.39
|
4.49
|
1.42
|
12.6
|
10.5
|
2.15
|
Capex / Sales
|
1.53%
|
1.41%
|
0.52%
|
4.28%
|
3.14%
|
0.89%
|
Announcement Date
|
02/05/19
|
30/06/20
|
18/05/21
|
16/05/22
|
02/05/23
|
26/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +20.88% | 2.81M | | +6.37% | 106B | | -10.78% | 59.59B | | +65.71% | 46.3B | | +15.59% | 38.48B | | +1.23% | 31.01B | | +9.63% | 19.84B | | +12.73% | 16.81B | | +9.04% | 13.95B | | -4.93% | 13B |
Other Commodity Chemicals
|